Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 1,351 citing Mellors: Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. (0.09 sec) 

Declining morbidity and mortality among patients with advanced human immunodeficiency …


FJ Palella, KM Delaney, AC Moorman, MO … - New England Journal of Medicine, 1998 - content.nejm.org
Results Mortality among the patients declined from 29.4 per 100 person-years in
1995 to 8.8 per 100 person-years in the second quarter of 1997. There were
reductions in mortality regardless of sex, race, age, and risk factors for ...
Cited by 5776 - Related articles - BL Direct - All 9 versions

A controlled trial of two nucleoside analogues plus indinavir in persons with human …

- mrc.ac.za [PDF] 
SM Hammer, KE Squires, MD Hughes, JM Grimes … - New England Journal of Medicine, 1997 - content.nejm.org
Methods A total of 1156 patients not previously treated with lamivudine or
protease inhibitors were stratified according to CD4 cell count (50 or fewer vs.
51 to 200 cells per cubic millimeter) and randomly assigned to one of two ...
Cited by 1138 - Related articles - BL Direct - All 12 versions

[PDF] Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the …


CC Carpenter, MA Fischl, SM Hammer, MS … - Jama, 1997 - strokecenter.org
From Brown University School of Medicine, Providence, RI (Dr Carpenter);
University of Miami School of Medicine, Miami, Fla (Dr Fischl); Harvard Medical
School, Boston, Mass (Drs Hammer and Hirsch); International AIDS ...
Cited by 785 - Related articles - View as HTML - BL Direct - All 6 versions

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the …

- bcpwa.org [PDF] 
PG Yeni, SM Hammer, CCJ Carpenter, DA … - Jama, 2002 - Am Med Assoc
Evidence and Consensus Process The full panel was convened in late 2000 and
assigned 7 section committees. A section writer and 3 to 5 section committee
members (each panel member served on numerous sections) identified relevant ...
Cited by 686 - Related articles - BL Direct - All 12 versions

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a …

- tulane.edu [PDF] 
M Egger, M May, G ChĂȘne, AN Phillips, B … - The Lancet, 2002 - Elsevier
During 24 310 person-years of follow up, 1094 patients developed AIDS or died
and 344 patients died. Baseline CD4 cell count was strongly associated with the
probability of progression to AIDS or death: compared with patients ...
Cited by 667 - Related articles - All 11 versions

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of …


PM Garcia, LA Kalish, J Pitt, H Minkoff, TC … - The New England journal of medicine, 1999 - nejm.highwire.org
Methods We measured plasma HIV-1 RNA serially in 552 women with HIV-1 infection
who had singleton pregnancies. The status of infection in their infants was
assessed by culture of blood and further classified as early (if a culture ...
Cited by 498 - Related articles - BL Direct - All 5 versions

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple …

- zhaoys.com [PDF] 
RS Hogg, B Yip, KJ Chan, E Wood, KJP … - Jama, 2001 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better.
Cited by 498 - Related articles - BL Direct - All 4 versions

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS …

- barry.edu [PDF] 
E Gonzalez, H Kulkarni, H Bolivar, A … - Science, 2005 - sciencemag.org
Segmental duplications in the human genome are selectively enriched for genes
involved in immunity, although the phenotypic consequences for host defense are
unknown. We show that there are significant interindividual and ...
Cited by 449 - Related articles - All 12 versions

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

- nih.gov
CJ Petropoulos, NT Parkin, KL Limoli, YS … - Antimicrobial agents and chemotherapy, 2000 - aac.highwire.org
Although combination antiretroviral therapy has resulted in a considerable
improvement in the treatment of human immunodeficiency virus (HIV) type 1
(HIV-1) infection, the emergence of resistant virus is a significant ...
Cited by 426 - Related articles - BL Direct - All 10 versions

Consistent viral evolutionary changes associated with the progression of human …

- nih.gov
R Shankarappa, JB Margolick, SJ Gange, AG … - Journal of Virology, 1999 - Am Soc Microbiol
To understand the high variability of the asymptomatic interval between primary
human immunodeficiency virus type 1 (HIV-1) infection and the development of
AIDS, we studied the evolution of the C2-V5 region of the HIV-1 env gene ...
Cited by 392 - Related articles - BL Direct - All 9 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google